prednisolone has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 56 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Massive pleural effusion developed in a 59-year-old male patient with chronic myeloid leukemia, who was being treated with bosutinib." | 8.31 | Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors. ( Aslan, NA; Elver, Ö; Erol, V; Güler, N; Hıncal, HO, 2023) |
| " daily) caused a decrease in fibrinogen levels in nine patients treated for lymphoid blast crisis LBC) of chronic myeloid leukemia (CML)." | 7.68 | Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia. ( Bettelheim, P; Korninger, C; Lechner, K; Pabinger-Fasching, I; Speiser, W; Stain, M; Sunder-Plassmann, G, 1991) |
| " Cyclosporine, methotrexate and prednisone were used for graft-versus-host disease (GVHD) prophylaxis." | 5.07 | Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide. ( Angelucci, E; Baronciani, D; Erer, B; Galimberti, M; Gaziev, D; Giardini, C; Lucarelli, G; Polchi, P; Rapa, S; Ripalti, M, 1994) |
| "Massive pleural effusion developed in a 59-year-old male patient with chronic myeloid leukemia, who was being treated with bosutinib." | 4.31 | Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors. ( Aslan, NA; Elver, Ö; Erol, V; Güler, N; Hıncal, HO, 2023) |
| " The co-administration of prednisolone was thus tried, and she has been able to continue imatinib mesylate administration without any liver dysfunction and finally was able to obtain a complete cytogenetic response." | 3.73 | Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management. ( Ikuta, K; Inamura, J; Jimbo, J; Kohgo, Y; Miyokawa, N; Sato, K; Shindo, M; Tokusashi, Y; Torimoto, Y, 2005) |
| " This occurred during an exacerbation of graft-versus-host disease (GVHD) and both problems remitted after therapy with cyclosporine and prednisolone." | 3.68 | Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient. ( Barbara, JA; Gillis, D; Ho, JO; Smith, PS; Thomas, AC; Woodroffe, AJ, 1992) |
| " daily) caused a decrease in fibrinogen levels in nine patients treated for lymphoid blast crisis LBC) of chronic myeloid leukemia (CML)." | 3.68 | Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia. ( Bettelheim, P; Korninger, C; Lechner, K; Pabinger-Fasching, I; Speiser, W; Stain, M; Sunder-Plassmann, G, 1991) |
| "The drug is used for the treatment of chronic myeloid leukemia, malignant gastrointestinal stromal tumors, and some other conditions." | 2.44 | Oral and cutaneous lichenoid reaction with nail changes secondary to imatinib: report of a case and literature review. ( Pubalan, M; Wahiduzzaman, M, 2008) |
| " Imatinib mesylate, a recently introduced specific tyrosine kinase inhibitor of BCR-ABL, in combination with chemotherapy, resulted in more than 90% hematologic CR in adult Ph-positive ALL, including molecular CR in more than 50% of patients." | 2.43 | Treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy. ( Ohno, R, 2006) |
| "Sweet's syndrome (SS), acute febrile neutrophilic dermatosis, has been linked to hematologic malignancies and presents with characteristic edematous dermal plaques." | 2.40 | Sweet's syndrome without granulocytosis. ( al-Mondhiry, H; Ballard, J; Ehmann, WC; Helm, KF; Probert, C, 1998) |
| "We describe a patient with chronic myelogenous leukemia (CML) and a patient with hairy cell leukemia being effectively treated with alpha-interferon who developed a seropositive chronic polyarthritis formally fulfilling the ACR criteria for rheumatoid arthritis." | 2.40 | [Interferon-alpha-associated polyarthritis. Possible induction of seropositive rheumatoid arthritis by interferon-alpha: two case reports and review of the literature]. ( Einsele, H; Kanz, L; Kötter, I; Mohren, M; Müller, CA, 1999) |
| "Ph1-positive chronic myelocytic leukemia (CML) developing in a treated case of acute promyelocytic leukemia (APL) is reported." | 2.38 | [Chronic myelocytic leukemia following chemotherapy of acute promyelocytic leukemia]. ( Maruyama, Y; Nagata, K; Nakamura, S; Onozawa, Y; Sakamaki, H; Yahara, Y, 1989) |
| "Immune thrombocytopenia (ITP) and chronic myeloid leukemia (CML) are rarely observed concurrently." | 1.91 | Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia. ( Itoh, Y; Nakamura, Y; Wakimoto, N, 2023) |
| "We discuss a case of nilotinib-induced interstitial lung disease presenting with nonspecific interstitial pneumonia on the unilateral lung." | 1.72 | A case report of nilotinib-induced irreversible interstitial lung disease. ( Cho, JY; Kim, D; Kwon, J; Lee, OJ; Shin, YM, 2022) |
| "A 61-year-old patient with chronic myeloid leukemia was treated with IM at 400 mg daily dose." | 1.62 | Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia. ( Charfi, M; Elloumi, M; Kallel, F; Kassar, O; Ksouda, K; Maaloul, I, 2021) |
| "Dasatinib was discontinued and the patient received intravenous immunoglobulin (IVIg), resulting in resolution of the symptoms." | 1.48 | Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia. ( Akagawa, N; Higashihara, M; Iizuka, T; Ishida, T; Miyata, T; Miyazaki, K; Suzuki, T; Tominaga, N, 2018) |
| "The abnormal cell types in chronic myeloid leukemia (CML) and monoclonal gammopathy of uncertain (MGUS) are quite different, being myeloid and plasma cells, respectively." | 1.48 | Prevalence of monoclonal gammopathy of uncertain significance in chronic myeloid leukemia: A case report. ( Lu, S; Ouyang, W; Wang, Z; Zhao, X, 2018) |
| "We present a case of nilotinib-induced interstitial lung disease (ILD)." | 1.39 | Nilotinib-induced interstitial lung disease. ( Go, SI; Kang, JH; Kang, MH; Kim, HG; Lee, GW; Lee, JH; Lee, WS, 2013) |
| "Treatment with prednisolone (1 mg/kg/d) began on approximately day 300." | 1.31 | Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. ( Kuwana, M; Mashima, Y; Mori, T; Nakajima, T; Ogawa, Y; Oguchi, Y; Okamoto, S; Tsubota, K; Watanabe, R; Yamada, M, 2001) |
| "A 37-year-old Japanese man with chronic myeloid leukemia (CML) developed myasthenia gravis 29 months after bone marrow transplantation (BMT) from an HLA one locus-mismatched brother." | 1.29 | Myasthenia gravis after allogeneic bone marrow transplantation. ( Gondo, H; Harada, M; Nakamura, M; Niho, Y; Okamura, S; Otsuka, T; Sano, T; Shimoda, K, 1994) |
| "A case of nonoliguric acute renal failure complicated with tumor lysis syndrome is described." | 1.28 | [Nonoliguric acute renal failure complicated with tumor lysis syndrome in chronic myelocytic leukemia in lymphoid crisis]. ( Ishikawa, Y; Kobayashi, R; Matsumoto, T; Naito, H; Shikano, T; Tonooka, T, 1991) |
| "They were ALL(6), ANLL(8), CML(1) and NHL(1)." | 1.27 | [BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia]. ( Hatae, Y; Hatayama, Y; Nakadate, H; Takeda, T, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (16.07) | 18.7374 |
| 1990's | 17 (30.36) | 18.2507 |
| 2000's | 16 (28.57) | 29.6817 |
| 2010's | 10 (17.86) | 24.3611 |
| 2020's | 4 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, JY | 1 |
| Lee, OJ | 1 |
| Kwon, J | 1 |
| Kim, D | 1 |
| Shin, YM | 1 |
| Aslan, NA | 1 |
| Hıncal, HO | 1 |
| Elver, Ö | 1 |
| Erol, V | 1 |
| Güler, N | 1 |
| Nakamura, Y | 3 |
| Itoh, Y | 1 |
| Wakimoto, N | 1 |
| Kallel, F | 1 |
| Kassar, O | 1 |
| Maaloul, I | 1 |
| Charfi, M | 1 |
| Ksouda, K | 1 |
| Elloumi, M | 1 |
| Ishida, T | 1 |
| Akagawa, N | 1 |
| Miyata, T | 1 |
| Tominaga, N | 1 |
| Iizuka, T | 1 |
| Higashihara, M | 1 |
| Suzuki, T | 1 |
| Miyazaki, K | 1 |
| Kopp, CR | 1 |
| Jandial, A | 1 |
| Mishra, K | 1 |
| Sandal, R | 1 |
| Malhotra, P | 1 |
| Ouyang, W | 1 |
| Zhao, X | 1 |
| Lu, S | 1 |
| Wang, Z | 1 |
| Boo, YL | 1 |
| Liam, CCK | 1 |
| Toh, SG | 1 |
| Lim, SM | 1 |
| Santopietro, M | 1 |
| Miano, M | 1 |
| Palumbo, G | 1 |
| Zhang, K | 1 |
| Cardarelli, L | 1 |
| Chiaretti, S | 1 |
| Peragine, N | 1 |
| Nanni, M | 1 |
| Diverio, D | 1 |
| Mancini, F | 1 |
| Testi, AM | 1 |
| Moleti, ML | 1 |
| Foà, R | 1 |
| Giona, F | 1 |
| Go, SI | 1 |
| Lee, WS | 1 |
| Lee, GW | 1 |
| Kang, JH | 1 |
| Kang, MH | 1 |
| Lee, JH | 1 |
| Kim, HG | 1 |
| Lee, HY | 1 |
| Lee, KH | 1 |
| Hyun, MS | 1 |
| Kim, MK | 1 |
| Koh, SA | 1 |
| Cho, HS | 1 |
| Eishei Oskuei, A | 1 |
| Makhdoomi, K | 1 |
| Abkhiz, S | 1 |
| Vossoghian, S | 1 |
| Farrokhpour, M | 1 |
| Tokita, K | 1 |
| Nagasawa, F | 1 |
| Takahashi, W | 1 |
| Sasaki, K | 1 |
| Ichikawa, M | 1 |
| Mitani, K | 1 |
| Wahiduzzaman, M | 1 |
| Pubalan, M | 1 |
| Nagasaki, Y | 1 |
| Miyamoto, T | 1 |
| Henzan, H | 1 |
| Nagafuji, K | 1 |
| Harada, M | 2 |
| Akashi, K | 1 |
| Matsunaga, T | 1 |
| Cunningham, S | 1 |
| Muneer, S | 1 |
| Ranganathan, A | 1 |
| Shrader, M | 1 |
| Ohno, R | 1 |
| Suehiro, T | 1 |
| Masutani, K | 1 |
| Yokoyama, M | 1 |
| Tokumoto, M | 1 |
| Tsuruya, K | 1 |
| Fukuda, K | 1 |
| Kanai, H | 1 |
| Katafuchi, R | 1 |
| Nagatoshi, Y | 1 |
| Hirakata, H | 1 |
| Au, WY | 1 |
| Ma, SK | 1 |
| Wan, TS | 1 |
| Wang, EP | 1 |
| Lau, TC | 1 |
| Kwong, YL | 1 |
| INAI, S | 1 |
| FUJIKAWA, K | 1 |
| MASAOKA, T | 1 |
| TAKAHASHI, H | 1 |
| NAGAKI, K | 1 |
| SPASSKII, OV | 1 |
| MURTHY, BG | 1 |
| Murakami, T | 1 |
| Shibazaki, K | 1 |
| Kurokawa, K | 1 |
| Ichikawa, Y | 1 |
| Ohsawa, Y | 1 |
| Sunada, Y | 1 |
| Isshiki, I | 1 |
| Yamaguchi, K | 1 |
| Okamoto, S | 2 |
| Arimura, K | 1 |
| Arima, N | 1 |
| Ohtsubo, H | 1 |
| Matsushita, K | 1 |
| Kukita, T | 1 |
| Ayukawa, T | 1 |
| Kuroki, T | 1 |
| Tei, C | 1 |
| Ikuta, K | 1 |
| Torimoto, Y | 1 |
| Jimbo, J | 1 |
| Inamura, J | 1 |
| Shindo, M | 1 |
| Sato, K | 1 |
| Tokusashi, Y | 1 |
| Miyokawa, N | 1 |
| Kohgo, Y | 1 |
| Al Sobhi, E | 1 |
| Zahrani, Z | 1 |
| Zevallos, E | 1 |
| Zuraiki, A | 1 |
| Govind Babu, K | 1 |
| Attili, VS | 1 |
| Bapsy, PP | 1 |
| Anupama, G | 1 |
| Shimoda, K | 1 |
| Gondo, H | 1 |
| Sano, T | 1 |
| Nakamura, M | 1 |
| Otsuka, T | 1 |
| Okamura, S | 1 |
| Niho, Y | 1 |
| Galimberti, M | 1 |
| Polchi, P | 1 |
| Lucarelli, G | 1 |
| Angelucci, E | 1 |
| Baronciani, D | 1 |
| Giardini, C | 1 |
| Gaziev, D | 1 |
| Erer, B | 1 |
| Ripalti, M | 1 |
| Rapa, S | 1 |
| Mughal, T | 1 |
| Morleda, J | 1 |
| Goldman, J | 1 |
| Kitabayashi, A | 1 |
| Miura, I | 1 |
| Ito, T | 1 |
| Takahashi, M | 2 |
| Chubachi, A | 1 |
| Niitsu, H | 1 |
| Mamiya, S | 1 |
| Miura, AB | 1 |
| Kuyama, J | 1 |
| Take, H | 1 |
| Mahé, B | 1 |
| Gaillard, F | 1 |
| Labadie, F | 1 |
| Papin, S | 1 |
| Letortorec, S | 1 |
| Moreau, P | 1 |
| Harousseau, JL | 1 |
| Milpied, N | 1 |
| Fleischman, EW | 1 |
| Volkova, MA | 1 |
| Frenkel, MA | 1 |
| Konstantinova, LN | 1 |
| Kulagina, OE | 1 |
| Baranov, AE | 1 |
| Gordeeva, AA | 1 |
| Gerber, M | 1 |
| Gmeinhart, B | 1 |
| Volc-Platzer, B | 1 |
| Kalhs, P | 1 |
| Greinix, H | 1 |
| Knobler, R | 1 |
| Probert, C | 1 |
| Ehmann, WC | 1 |
| al-Mondhiry, H | 1 |
| Ballard, J | 1 |
| Helm, KF | 1 |
| Brandenburg, U | 1 |
| Gottlieb, D | 1 |
| Bradstock, K | 1 |
| Kötter, I | 1 |
| Müller, CA | 1 |
| Einsele, H | 1 |
| Mohren, M | 1 |
| Kanz, L | 1 |
| Ogawa, Y | 1 |
| Kuwana, M | 1 |
| Mori, T | 1 |
| Watanabe, R | 1 |
| Nakajima, T | 1 |
| Yamada, M | 1 |
| Mashima, Y | 1 |
| Tsubota, K | 1 |
| Oguchi, Y | 1 |
| Giles, FJ | 1 |
| Kantarjian, H | 1 |
| O'Brien, S | 1 |
| Rios, MB | 1 |
| Cortes, J | 1 |
| Beran, M | 1 |
| Koller, C | 1 |
| Keating, M | 1 |
| Talpaz, M | 1 |
| Hambach, L | 1 |
| Eder, M | 1 |
| Dammann, E | 1 |
| Battmer, K | 1 |
| Stucki, A | 1 |
| Heil, G | 1 |
| Ganser, A | 1 |
| Hertenstein, B | 1 |
| Yamaguchi, H | 1 |
| Inokuchi, K | 1 |
| Yokomizo, E | 1 |
| Miyata, J | 1 |
| Watanabe, A | 1 |
| Inami, M | 1 |
| Tajika, K | 1 |
| Dan, K | 1 |
| Chou, T | 1 |
| Wakabayashi, M | 1 |
| Hayashi, N | 1 |
| Arakawa, M | 1 |
| Kawakubo, K | 1 |
| Ohyashiki, JH | 1 |
| Ohyashiki, K | 1 |
| Tauchi, T | 1 |
| Ohto, T | 1 |
| Toyama, K | 1 |
| Barbara, JA | 1 |
| Thomas, AC | 1 |
| Smith, PS | 1 |
| Gillis, D | 1 |
| Ho, JO | 1 |
| Woodroffe, AJ | 1 |
| Kobayashi, R | 1 |
| Naito, H | 1 |
| Shikano, T | 1 |
| Ishikawa, Y | 1 |
| Matsumoto, T | 1 |
| Tonooka, T | 1 |
| Sunder-Plassmann, G | 1 |
| Speiser, W | 1 |
| Korninger, C | 1 |
| Stain, M | 1 |
| Bettelheim, P | 1 |
| Pabinger-Fasching, I | 1 |
| Lechner, K | 1 |
| Collin, R | 1 |
| Griffiths, H | 1 |
| Polacarz, SV | 1 |
| Lawrence, AC | 1 |
| Watmore, A | 1 |
| Yoshizaki, N | 1 |
| Kohda, K | 1 |
| Nakazawa, O | 1 |
| Ando, M | 1 |
| Miyazaki, S | 1 |
| Muramatsu, H | 1 |
| Terada, S | 1 |
| Kure, T | 1 |
| Niitsu, Y | 1 |
| Kitajima, K | 2 |
| Nakada, H | 2 |
| Sakamaki, H | 1 |
| Nakamura, S | 1 |
| Maruyama, Y | 1 |
| Nagata, K | 1 |
| Yahara, Y | 1 |
| Onozawa, Y | 1 |
| Adachi, T | 1 |
| Takahashi, I | 1 |
| Osada, K | 1 |
| Fukuda, S | 1 |
| Ohmoto, E | 1 |
| Aoyama, S | 1 |
| Yorimitsu, S | 1 |
| Sanada, H | 1 |
| Nakadate, H | 1 |
| Hatayama, Y | 1 |
| Hatae, Y | 1 |
| Takeda, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Investigator Initiated Open Study to Evaluate the Efficacy and Safety of Intra Arterial Infusion for Treatment of Steroid Resistant Acute Hepatic Graft Versus Host Disease (AGVHD)[NCT01140984] | 2 participants (Actual) | Interventional | 2010-09-30 | Terminated (stopped due to technical issues) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for prednisolone and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow Examination; Chemorad | 2014 |
Oral and cutaneous lichenoid reaction with nail changes secondary to imatinib: report of a case and literature review.
Topics: Administration, Oral; Administration, Topical; Adult; Benzamides; Clobetasol; Drug Administration Sc | 2008 |
[Clinical progress in chronic myelogenous leukemia].
Topics: Benzamides; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Dasatinib; Drug Discover | 2009 |
Treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cycloph | 2006 |
Diffuse proliferative glomerulonephritis after bone marrow transplantation.
Topics: Adolescent; Anti-Inflammatory Agents; Bone Marrow Transplantation; Glomerulonephritis, Membranoproli | 2002 |
Sweet's syndrome without granulocytosis.
Topics: Acute Disease; Adult; Antineoplastic Agents; Biopsy; Diagnosis, Differential; Drug Eruptions; Female | 1998 |
[Interferon-alpha-associated polyarthritis. Possible induction of seropositive rheumatoid arthritis by interferon-alpha: two case reports and review of the literature].
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Female; Humans; Injections, | 1999 |
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation | 2001 |
Philadelphia chromosome-positive acute myeloid leukemia with tetraploidy.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Daunor | 2002 |
[A case of chronic myelogenous leukemia complicated with nephrotic syndrome].
Topics: Aged; Aged, 80 and over; Busulfan; Drug Therapy, Combination; Female; Glomerulonephritis, Membranopr | 1989 |
[Chronic myelocytic leukemia following chemotherapy of acute promyelocytic leukemia].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Leuke | 1989 |
3 trials available for prednisolone and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Cyclopho | 1994 |
Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort | 2001 |
[Treatment of chronic myelogenous leukemia (CML)--VP(M) regimen starting during its chronic phase, and the second nation-wide survey on the long-term survivors of CML in Japan].
Topics: Adolescent; Adult; Aged; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Female; Humans | 1989 |
42 other studies available for prednisolone and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
A case report of nilotinib-induced irreversible interstitial lung disease.
Topics: Adrenal Cortex Hormones; Biopsy; Cough; Humans; Idiopathic Interstitial Pneumonias; Leukemia, Myelog | 2022 |
Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors.
Topics: Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pleural Effu | 2023 |
Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia.
Topics: Adrenal Cortex Hormones; Chronic Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, | 2023 |
Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia.
Topics: Alveolitis, Extrinsic Allergic; Antineoplastic Agents; Humans; Imatinib Mesylate; Leukemia, Myelogen | 2021 |
Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia.
Topics: Acute Disease; Antineoplastic Agents; Dasatinib; Demyelinating Diseases; Drug Substitution; Female; | 2018 |
Myasthenia gravis unmasked by imatinib.
Topics: Adult; Blepharoptosis; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; | 2019 |
Prevalence of monoclonal gammopathy of uncertain significance in chronic myeloid leukemia: A case report.
Topics: Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Mo | 2018 |
Rechallenge of ponatinib in chronic myeloid leukaemia after hepatotoxicity.
Topics: Adult; Chemical and Drug Induced Liver Injury; Humans; Imidazoles; Leukemia, Myelogenous, Chronic, B | 2019 |
Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; | 2019 |
Nilotinib-induced interstitial lung disease.
Topics: Aged; Benzamides; Diagnosis, Differential; Drug Substitution; Female; Glucocorticoids; Humans; Imati | 2013 |
Successful treatment of Chronic Myelogenic Leukemia (CML) with imatinib after renal transplantation.
Topics: Antineoplastic Agents; Benzamides; Cyclosporine; Humans; Imatinib Mesylate; Immunosuppressive Agents | 2014 |
Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis.
Topics: Acute-Phase Reaction; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparag | 2016 |
Longstanding remission of adult onset Still's disease under imatinib therapy in a patient with chronic myelogenous leukemia.
Topics: Adult; Benzamides; Drug Resistance; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-A | 2009 |
The 51st annual meeting of the American Society of Hematology.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
Concurrent mediastinal B cell lymphoma and chronic myeloid leukemia with an unusually favorable response to chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Clone Cells; Combined Modal | 2003 |
DEFICIENCY OF THE HYDRAZINE SENSITIVE COMPONENT OF COMPLEMENT IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA.
Topics: Animals; Blood Protein Electrophoresis; Busulfan; Complement System Proteins; Erythrocytes; Guinea P | 1963 |
[COMBINED TREATMENT OF CHRONIC MYELOCYTIC LEUKEMIA].
Topics: Blood Transfusion; Busulfan; Cortisone; Erythrocyte Count; Hemoglobinometry; Humans; Leukemia; Leuke | 1963 |
SKIN LESIONS IN CHRONIC MYELOID LEUKAEMIA.
Topics: Blood Transfusion; Busulfan; Dermatology; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL | 1964 |
Conduction block of varicella zoster virus neuropathy.
Topics: Action Potentials; Acyclovir; Antiviral Agents; Electrodiagnosis; Electromyography; Female; Glucocor | 2003 |
Interstitial pneumonitis during imatinib therapy.
Topics: Aged; Antineoplastic Agents; Benzamides; Female; Glucocorticoids; Humans; Imatinib Mesylate; Leukemi | 2004 |
Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia.
Topics: Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Interferon-alpha; Leukemia, My | 2004 |
Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management.
Topics: Antineoplastic Agents; Benzamides; Biopsy; Chemical and Drug Induced Liver Injury; Enzyme Inhibitors | 2005 |
Imatinib-induced immune hepatitis: case report and literature review.
Topics: Adolescent; Alanine Transaminase; Antibodies, Antinuclear; Antibody Specificity; Antineoplastic Agen | 2007 |
Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.
Topics: Antineoplastic Agents; Benzamides; Glucocorticoids; Humans; Imatinib Mesylate; Leukemia, Myelogenous | 2007 |
Myasthenia gravis after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; HLA-B7 Ant | 1994 |
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Co | 1993 |
[Partial and complete disappearance of Ph1 chromosome in two patients with chronic myelogenous leukemia after conventional chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Female; Humans; Leukemia, Mye | 1993 |
[Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Daunorubic | 1995 |
Occurrence of a T cell lymphoma in a patient with chronic myeloid leukemia treated with alpha interferon.
Topics: Anemia, Hemolytic, Autoimmune; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Pro | 1995 |
Translocation (2;3)(p13;q26) in two cases of myeloid malignancies. Acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Humans; Karyoty | 1996 |
Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporine; Extracorporeal Circulation; Female; Graft | 1997 |
Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glucocorticoids; Graft vs Host | 1998 |
Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Dry Eye Syndromes; Female; Glucocorticoids; Graft | 2001 |
[Treatment of leukemia: discussion].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined | 1992 |
[Treatment of CML with blastic crisis by the combination therapy of VP and low-dose Ara-C].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Humans; Leukemia, M | 1992 |
Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marro | 1992 |
Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient.
Topics: Adult; Antibodies, Antinuclear; Biopsy; Bone Marrow Transplantation; Cyclosporine; Fluorescent Antib | 1992 |
[Nonoliguric acute renal failure complicated with tumor lysis syndrome in chronic myelocytic leukemia in lymphoid crisis].
Topics: Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Blood | 1991 |
Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia.
Topics: Adult; Aged; Antithrombin III; Blast Crisis; Disseminated Intravascular Coagulation; Female; Fibrin | 1991 |
Mithramycin therapy for resistant hypercalcaemia in transformed chronic granulocytic leukaemia.
Topics: Adult; Blast Crisis; Female; Fluid Therapy; Humans; Hypercalcemia; Leukemia, Myelogenous, Chronic, B | 1989 |
[Chemotherapy of chronic myelogenous leukemia--VP(M) regimen initiated during its chronic phase, and evaluation of MCNU in the phase of blastic crisis].
Topics: Adolescent; Adult; Aged; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; | 1989 |
[BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia].
Topics: Aclarubicin; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 1988 |